6Berger A, Smith M, Lidsky L, et al. Opioid use and health care charges at the end of life in patients with metastatic cancer. Manag Care Interface 2004; 17(4):28-34.
7Portenoy Rk, Sciberras A, Eliot L, et al. Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe. J Pain Symptom Manage 2002; 23 (4):292 -300.
9Cherny N, Ripaaonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001; 19 (9): 2542 - 54.
10World Health Organization. Cancer Pain Relief 2nd ed. Geneva: WHO Office of Publication 1996.
